These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9426381)

  • 21. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G proteins and regulation of pyruvate dehydrogenase activity by insulin in human circulating lymphocytes.
    Curto M; Piccinini M; Rabbone I; Mioletti S; Mostert M; Bruno R; Rinaudo MT
    Int J Biochem Cell Biol; 1997 Oct; 29(10):1207-17. PubMed ID: 9438382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of pyruvate dehydrogenase phosphatase in obese subjects is a defect that signals insulin resistance.
    Piccinini M; Mostert M; Alberto G; Ramondetti C; Novi RF; Dalmasso P; Rinaudo MT
    Obes Res; 2005 Apr; 13(4):678-86. PubMed ID: 15897476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.
    Haffner SM; Howard G; Mayer E; Bergman RN; Savage PJ; Rewers M; Mykkänen L; Karter AJ; Hamman R; Saad MF
    Diabetes; 1997 Jan; 46(1):63-9. PubMed ID: 8971083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of in vitro sensitivities of glucose transport and antilipolysis to insulin in NIDDM.
    Yki-Järvinen H; Kubo K; Zawadzki J; Lillioja S; Young A; Abbott W; Foley JE
    Am J Physiol; 1987 Sep; 253(3 Pt 1):E300-4. PubMed ID: 3307452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of pyruvate dehydrogenase to insulin in activated T lymphocytes. Lack of responsiveness to insulin in patients with polycystic ovarian disease and diabetes.
    Buffington CK; Givens JR; Kitabchi AE
    Diabetes; 1990 Mar; 39(3):361-8. PubMed ID: 2407584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization.
    Hollenbeck CB; Chen YD; Reaven GM
    Diabetes; 1984 Jul; 33(7):622-6. PubMed ID: 6376218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced glucose-induced thermogenesis is present in noninsulin-dependent diabetes mellitus without obesity.
    Gumbiner B; Thorburn AW; Henry RR
    J Clin Endocrinol Metab; 1991 Apr; 72(4):801-7. PubMed ID: 2005204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyper insulinism and decreased insulin sensitivity in nonobese healthy offspring of conjugal diabetic parents and individuals with IGT and NIDDM.
    Rao CA; Snehalatha C
    Indian J Physiol Pharmacol; 1996 Apr; 40(2):139-44. PubMed ID: 9062808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus.
    Chen YD; Golay A; Swislocki AL; Reaven GM
    J Clin Endocrinol Metab; 1987 Jan; 64(1):17-21. PubMed ID: 3782431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus.
    Katsuki A; Sumida Y; Murashima S; Murata K; Takarada Y; Ito K; Fujii M; Tsuchihashi K; Goto H; Nakatani K; Yano Y
    J Clin Endocrinol Metab; 1998 Mar; 83(3):859-62. PubMed ID: 9506740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
    Garvey WT; Maianu L; Huecksteadt TP; Birnbaum MJ; Molina JM; Ciaraldi TP
    J Clin Invest; 1991 Mar; 87(3):1072-81. PubMed ID: 1999488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The response of serum ghrelin and PYY to oral glucose and steamed-bread tolerance test in nonobese and obese patients with type 2 diabetes].
    An ZM; Zhang L; Zhang M; Huang MJ; Xiong ZY; Zhang GF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):772-5. PubMed ID: 19024311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
    Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
    Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
    Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
    Simoneau JA; Kelley DE
    J Appl Physiol (1985); 1997 Jul; 83(1):166-71. PubMed ID: 9216960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.